Fund Holdings — MPM BioImpact LLC

Total Portfolio Value:
$1.30B
Total Bought:
$318.50M
Total Sold:
$579.85M
Net Transaction:
-$261.35M
Notable People:
Ansbert K Gadicke
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Cullinan Therapeutics, Inc.(CGEM)9,731,3419,721,081-10,260$177.21M$149.22M11.49%-$27.99M
Aktis Oncology, Inc.(AKTS)4,835,8724,835,8720$155.86M$94.15M7.25%-$61.71M
Travere Therapeutics, Inc.(TVTX)1,122,7311,088,363-34,368$63.78M$64.08M4.93%+$300.5K
Edgewise Therapeutics, Inc.(EWTX)1,620,7801,575,987-44,793$65.85M$63.99M4.93%-$1.87M
Dyne Therapeutics, Inc.(DYN)1,922,0933,208,146+1,286,053$42.69M$51.68M3.98%+$8.99M
Corcept Therapeutics Incorporated(CORT)771,028422,000-349,028$67.04M$48.63M3.74%-$18.41M
Relay Therapeutics, Inc.(RLAY)2,415,6722,369,578-46,094$45.20M$42.77M3.29%-$2.43M
Trevi Therapeutics, Inc.(TRVI)3,073,5772,978,906-94,671$57.32M$42.66M3.28%-$14.66M
Iovance Biotherapeutics, Inc.(IOVA)02,835,734+2,835,734$0$42.03M3.24%+$42.03M
Liquidia Corporation(LQDA)1,386,1741,342,713-43,461$110.52M$40.63M3.13%-$69.89M
Natera, Inc.(NTRA)92,63890,585-2,053$25.15M$37.44M2.88%+$12.29M
UroGen Pharma Ltd.(URGN)933,415909,691-23,724$34.35M$36.96M2.85%+$2.61M
Immunocore Holdings plcADS(IMCR)01,203,289+1,203,289$0$36.45M2.81%+$36.45M
DBV Technologies S.A.ADS(DBVT)3,666,2843,044,659-621,625$60.13M$35.81M2.76%-$24.32M
Taysha Gene Therapies, Inc.(TSHA)4,500,0007,262,959+2,762,959$30.64M$35.37M2.72%+$4.73M
ABIVAX Société AnonymeADR(ABVX)336,347328,379-7,968$44.82M$32.52M2.50%-$12.31M
Vir Biotechnology, Inc.(VIR)02,809,711+2,809,711$0$31.41M2.42%+$31.41M
Adlai Nortye Group Ltd.ADS(ANL)1,936,2911,956,618+20,327$22.27M$31.31M2.41%+$9.04M
Verastem, Inc.(VSTM)03,851,604+3,851,604$0$31.01M2.39%+$31.01M
uniQure N.V.(QURE)1,225,8551,201,413-24,442$56.46M$29.03M2.23%-$27.44M
Odyssey Therapeutics, Inc.01,289,091+1,289,091$0$28.64M2.20%+$28.64M
Tarsus Pharmaceuticals, Inc.(TARS)322,007352,676+30,669$20.27M$27.72M2.13%+$7.46M
Palvella Therapeutics, Inc.(PVLA)204,027197,633-6,394$31.18M$27.26M2.10%-$3.92M
Aclaris Therapeutics, Inc.(ACRS)1,042,4675,178,127+4,135,660$5.51M$27.24M2.10%+$21.72M
Oruka Therapeutics, Inc.(ORKA)0300,000+300,000$0$24.99M1.92%+$24.99M
ORIC Pharmaceuticals, Inc.(ORIC)1,882,1621,821,951-60,211$20.38M$24.54M1.89%+$4.16M
Stoke Therapeutics, Inc.(STOK)723,314925,133+201,819$23.67M$24.05M1.85%+$386.6K
Belite Bio, IncADR(BLTE)137,208133,387-3,821$21.13M$22.65M1.74%+$1.52M
Neurogene Inc.(NGNE)0771,839+771,839$0$21.47M1.65%+$21.47M
Zura Bio LimitedCL A(ZURA)4,472,8434,449,671-23,172$26.39M$18.51M1.42%-$7.88M
Annexon, Inc.(ANNX)3,544,3544,290,616+746,262$20.24M$18.15M1.40%-$2.09M
Monte Rosa Therapeutics, Inc.(GLUE)1,161,0811,125,216-35,865$28.10M$13.42M1.03%-$14.67M
BioAge Labs, Inc.(BIOA)1,667,6611,856,748+189,087$40.87M$13.16M1.01%-$27.71M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)01,667,272+1,667,272$0$11.37M0.88%+$11.37M
Bright Minds Biosciences Inc.(DRUG)202,114195,669-6,445$14.19M$9.75M0.75%-$4.44M
First Tracks Biotherapeutics Inc0254,374+254,374$0$9.02M0.69%+$9.02M
Alumis Inc2,019,0200-2,019,020$56.82M$0—-$56.82M
Context Therapeutics Inc.21077P108(CNTX)1,299,0460-1,299,046$719.5K$0—-$719.5K
Dianthus Therapeutics, Inc.(DNTH)420,0020-420,002$40.94M$0—-$40.94M
Entrada Therapeutics, Inc.29384C108(TRDA)1,253,0530-1,253,053$9.22M$0—-$9.22M
Forte Biosciences, Inc.34962G208987,4480-987,448$20.98M$0—-$20.98M
MoonLake Immunotherapeutics61559X104(MLTX)1,606,9670-1,606,967$31.29M$0—-$31.29M
Revolution Medicines, Inc.76155X100(RVMD)492,4830-492,483$92.23M$0—-$92.23M
Syndax Pharmaceuticals, Inc.87164F105(SNDX)1,333,5230-1,333,523$29.15M$0—-$29.15M
Ultragenyx Pharmaceutical Inc.90400D108(RARE)1,418,2150-1,418,215$47.35M$0—-$47.35M
Werewolf Therapeutics, Inc.95075A107(HOWL)80,1420-80,142$28.9K$0—-$28.9K
Page 1 of 1